Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.68 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.68 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.68 |
| ▸ | HTR2A | P28223 | 1/20 | 0.68 |
| ▸ | HTR2C | P28335 | 1/20 | 0.68 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.68 |
| ▸ | HRH1 | P35367 | 1/20 | 0.68 |
| ▸ | DRD3 | P35462 | 1/20 | 0.68 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.68 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.68 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.68 |
| ▸ | SLC1A2 | P43004 | 5/20 | 0.63 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.63 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.63 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.63 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.63 |
| ▸ | CPA1 | P15085 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12611015 | 0.90 | CHRM1 (0.83) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL1716831 | 0.86 | SLC1A2 (0.66) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL2386631 | 0.84 | CHRM1 (0.65) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL8939043 | 0.84 | CHRM1 (0.65) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL27749943 | 0.84 | CHRM1 (0.65) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL31544400 | 0.83 | SLC1A2 (0.56) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL1411995 | 0.83 | GRIK1 (0.68) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL2835497 | 0.83 | GRIK1 (0.68) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL2831405 | 0.83 | GRIK1 (0.68) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL2833540 | 0.83 | GRIK1 (0.68) | CHRM1AKR1A1CHRM3HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4444108-B1 | ALDEHYDE MIXTURES FOR FLAVOUR IMPROVEMENT | SYMRISE AG (DE) | 2025-09-10 | — | — | EP | claimed |
| EP-4161293-B1 | FLAVOURING COMPOSITION WITH BALANCED TASTE PROFILE | SYMRISE AG (DE) | 2024-01-31 | — | — | EP | claimed |
| EP-4161291-B1 | FLAVORING COMPOSITIONS FOR TASTE IMPROVEMENT | SYMRISE AG (DE) | 2023-11-01 | — | — | EP | claimed |
| EP-3088955-B1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHINETSU CHEMICAL CO (JP) | 2020-06-03 | — | — | EP | claimed |
| EP-3202876-B1 | FIXED BED DECOLORIZATION PROCESS FOR UNSATURATED FATTY ACID | ZHEJIANG MED XINCHANG PHARM (CN) | 2019-07-31 | — | — | EP | claimed |
| EP-3024918-B1 | MANGANESE CARBOXYLATES FOR PEROXYGEN ACTIVATION | ARKEMA INC (US) | 2019-07-03 | — | — | EP | claimed |
| EP-3032333-B1 | SHRINK MATERIAL AND PATTERN FORMING PROCESS | SHINETSU CHEMICAL CO (JP) | 2017-05-24 | — | — | EP | claimed |
| EP-3032332-B1 | SHRINK MATERIAL AND PATTERN FORMING PROCESS | SHINETSU CHEMICAL CO (JP) | 2017-04-05 | — | — | EP | claimed |
| US-20160168515-A1 | MANGANESE CARBOXYLATES FOR PEROXYGEN ACTIVATION | ARKEMA INC. | 2016-06-16 | — | — | US | claimed |
| EP-3024918-A1 | MANGANESE CARBOXYLATES FOR PEROXYGEN ACTIVATION | Arkema, Inc. (US) | 2016-06-01 | — | — | EP | claimed |
| WO-2015012879-A1 | MANGANESE CARBOXYLATES FOR PEROXYGEN ACTIVATION | ARKEMA INC. (US) | 2015-01-29 | — | — | WO | claimed |
| EP-1853713-B1 | Process for the isolation of polyhydroxyalkanoates (PHAs) from bacterial cells by solvent extraction | PHB IND SA (BR) | 2012-05-02 | — | — | EP | claimed |
| US-20050267168-A1 | Pentanoic acid derivatives | ONO PHARMACEUTICAL CO., LTD. | 2005-12-01 | — | — | US | claimed |
| US-20030096802-A1 | Pentanoic acid derivatives | ONO PHARMACEUTICAL CO., LTD. | 2003-05-22 | — | — | US | claimed |
| US-6201021-B1 | TREATMENT OF DISEASES INDUCED BY REACTIVE ASTROCYTES | ONO PHARMACEUTICAL CO., LTD. (JP) | 2001-03-13 | — | — | US | claimed |
| EP-0632008-B1 | Pentanoic acid derivatives | ONO PHARMACEUTICAL CO (JP) | 1998-02-04 | — | — | EP | claimed |
| EP-0632008-A1 | Pentanoic acid derivatives | ONO PHARMACEUTICAL CO., LTD. (JP) | 1995-01-04 | — | — | EP | claimed |
| US-12448306-B2 | Electrocatalytic bio-oil and wastewater treatment | BATTELLE MEMORIAL INSTITUTE (US) | 2025-10-21 | — | — | US | disclosed |
| CN-1186065-A | Method for producing trimethylhydroquinone diester | DAICEL CHEM (JP) | 1998-07-01 | — | — | CN | disclosed |
| US-5576459-A | Quaternary nitrogen or phosphorus chirates | SACHEM, INC. (US) | 1996-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050267168-A1 | Pentanoic acid derivatives | FFAR3, FFAR1, HCAR3 | CHRM1 93/4885AKR1A1 771/4885CHRM3 89/4885 |
| US-20030096802-A1 | Pentanoic acid derivatives | FFAR3, FPR1, FPR3 | CHRM1 84/4885AKR1A1 976/4885CHRM3 129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.